Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-31

Clinical Trial Update: Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ceftaroline fosamil versus vancomycin plus aztreonam for complicated skin and soft tissue infections; trial terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aztreonam (aztreonam)
  • Vancomycin (vancomycin)
  • ceftaroline fosamil (ceftaroline fosamil)

Snippet

Sponsor: Pfizer | Conditions: Complicated Skin and Soft Tissue Infection | Phase 3 | Status: TERMINATED | Results posted: 2016-03-31